{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP05184",
    "Peptide Name": "R[G4a]-SHa (RNST-2, Synthetic AMPs, retro-NST-2, XXD, XXA, UCLL1c; Derivative: RLFP-1; RLFP-2)",
    "Source": "Source: sequence reversal, designed, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLKGLMGVIASLF",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal",
      "Anti-MRSA",
      "Hemolytic",
      "Anticancer"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 2,
    "Boman Index": -2.05,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "69%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (64.29%) toLausporin-1L:23%, G=F: 15%.Chemical modification:  A10 is D-amino acid; C-terminal amidation.Activity: active against Gram+ S. aureus NCTC 13277 MRSA (MIC 3.12 uM), B. subtilis ATCC 23857 (MIC 1.56 uM), Gram- S. typhi ATCC 14028 (MIC 50 uM), E. coli ATCC 25922 (MIC 50 uM), P.aeruginosa ATCC 10145 (MIC 200 uM), and fungi C. albicans ATCC 36082 (MIC 15.6 uM).Structure:  helical in 20 mM SDS.In vitro toxicity: human RBC: HC50 13.8 uM; hemolytic. Breast cancer cells MCF-7 (IC50 53 uM), cervical cancer Hela cells (IC50 60 uM).SAR: conjugation of XX with the C-terminal lysine sidechain led to RLFP-1;\nconjugation of XX with the sidechain of K3 led to RLFP-2;",
    "Author": "Abdullah SJ, Guan JS, Mu Y, Bhattacharjya S.2024",
    "Reference": "Antibiotics (Basel). 2024 Dec 13;13(12):1213. doi: 10.3390/antibiotics13121213.PubMed",
    "Title": "Synthesis of Temporin-SHa Retro Analogs with Lysine Addition/Substitution and Antibiotic Conjugation to Enhance Antibacterial, Antifungal, and Anticancer Activities."
  },
  "3D Structure": []
}